$310.98
+2.54(0.82%)
Mkt Cap $33.2B
$206.32
$377.47
52-Week Range
At A Glance
1
BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies.
2
Revenue is primarily driven by Product (94.2%) and Collaboration (2.9%).
3
Most recently: of this Current Report on Form 8-K are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as ame (2026-02-26).
$33.2B
Market Cap
$455M
Revenue
$24M
Net Income
Employees11,000
Fundamentals
How The Business Makes Money
Revenue by Segment
Product94.2%($33.8B)
Collaboration2.9%($1.0B)
Other1%($363M)
Right To Access Intellectual Property Revenue0.6%($209M)
Collaboration Research And Development Service0.4%($159M)
Material Rights Revenue0.4%($144M)
Collaboration Other0.2%($63M)
Amgen Royalty Revenue0.1%($49M)
Novartis Broad Markets Revenue0.1%($45M)
Revenue by Geography
US51.4%($11.9B)
CN36.1%($8.4B)
Europe10.1%($2.4B)
All Other Countries Except China United States Of America And Switzerland2.4%($557M)
Activity